Cordlife Group (SG:P8A) has released an update.
Cordlife Group Limited has been directed by the Ministry of Health (MOH) to suspend new cord blood services in Singapore for up to an additional three months starting 15 June 2024. The company is working on rectification measures to address compliance issues and cannot yet determine the exact financial impact on its operations for the year. Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares during this period.
For further insights into SG:P8A stock, check out TipRanks’ Stock Analysis page.
